Inclusión de la inyección percutánea de etanol como primera línea de tratamiento de los quistes tiroideos sintomáticos

Agustín Ángel Merchante Alfaro,, Sandra Garzón Pastor, Susana Pérez Naranjo, Margarita González Boillos, Jacobo Blanco Dacal, Francisco Javier Maravall Royo, Pablo Abellán Galiana, Carlos Morillas Ariño

DOI: 10.1016/j.endinu.2020.09.010

Introducción

Nuestro objetivo es evaluar la eficacia y la seguridad del tratamiento mediante inyección percutánea de etanol guiada por ecografía (IPE-US) de los quistes tiroideos sintomáticos en 2 consultas de alta resolución (CAR) de nódulo tiroideo de la Comunidad Valenciana.

Pacientes y métodos

Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19: a case report

The Journal of Clinical Endocrinology & Metabolism, dgab557, 

https://doi.org/10.1210/clinem/dgab557

Published: 29 July 2021

Abstract

Context

Coronavirus disease 2019 (COVID-19) is a proinflammatory and prothrombotic condition, but its impact on adrenal function has not been adequately evaluated.

Case report

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

Published: August 06, 2021

DOI:https://doi.org/10.1016/S0140-6736(21)01443-4

Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-Based Setting

The Journal of Clinical Endocrinology & Metabolism, dgab468, 

https://doi.org/10.1210/clinem/dgab468

Published: 29 June 2021

Abstract

Context

While adrenal adenomas have been linked with cardiovascular morbidity in convenience samples of patients from specialized referral centers, large-scale population-based data are lacking.

Objective

Suscribirse a